Andrew Vyse

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Decision Making

Top Venues

Expert review of vaccines

Journal of medical economics

Epidemiology and infection

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Mendes, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary P E Slack, Gillian F Ellsbury, Tendai Mugwagwa
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease. Expert review of pharmacoeconomics & outcomes research 22 (8) (2022)
James Campling, Elizabeth Begier, Andrew Vyse, Catherine Hyams, Dave Heaton, Jo Southern, Adam Finn, Harish Madhava, Bradford D Gessner, Gillian F Ellsbury
A novel approach to estimate the local population denominator to calculate disease incidence for hospital-based health events in England. Epidemiology and infection 150 (2022)
James Campling, Hannah F Wright, Gillian C Hall, Tendai Mugwagwa, Andrew Vyse, Diana Mendes, Mary P E Slack, Gillian F Ellsbury
Hospitalization costs of adult community-acquired pneumonia in England. Journal of medical economics 25 (1) (2022)
Tendai Mugwagwa, Ahuva Averin, Mark Atwood, Reiko Sato, Andrew Vyse, James Campling, Derek Weycker, Mary P E Slack, Gillian F Ellsbury, Diana Mendes
Public health and budgetary impact of 20-valent pneumococcal conjugate vaccine for adults in England. Expert review of vaccines 21 (9) (2022)